Delivery Order SPE2DB22D3501-SPE2DB25FWU47
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Dupixent 300 mg/2 ml syringes with a ceiling value of $6,837.84. This delivery order represents a firm fixed price contract with no set-aside designation, meaning it was competitively awarded. The order is scheduled for completion by August 1, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Dupixent is a biologic medication...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Dupixent 300 mg/2 ml syringes, with a ceiling value of $10,375.34. This competitive, firm fixed-price delivery order is scheduled for completion by August 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's extensive pharmaceutical supply relationship with the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Dupixent 300 mg/2 ml syringes with a ceiling value of $3,418.92 under a firm fixed-price contract. This award represents a non-set-aside competitive procurement and is a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Dupixent 300 mg/2 mL syringes with a ceiling value of $19,847.17. This firm fixed-price delivery order, which is expected to be completed by August 4, 2025, represents a competitive, non-set-aside award. The pharmaceutical product will be sourced and distributed from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Dupixent 200 mg/1.14 mL syringes valued at $2,090.75, with an ultimate completion date of August 4, 2025. This non-set-aside, firm fixed-price delivery order is being performed at AmerisourceBergen's Conshohocken, Pennsylvania facility and represents a competitively awarded pharmaceutical supply transaction supporting federal medical procurement needs. This delivery order...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Dupixent 300 mg/2 mL syringes with a ceiling value of $44,107.24 under firm fixed-price terms. The contract, which is classified as a child order under a larger indefinite delivery vehicle, requires completion by July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Dupixent 300 mg/2 mL syringes with a ceiling value of $11,387.84. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order with an ultimate completion date of August 4, 2025. The award is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and constitutes a child contract under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on August 13, 2025, for Dupixent 200 mg/1.14 mL syringes with a ceiling value of $3,418.92 under a firm fixed-price contract type. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's capability to compete for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Dupixent 200 mg/1.14 mL syringes valued at $4,549.42. This is a firm fixed-price delivery order with an ultimate completion date of July 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's demonstrated capability...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $27,256.30 on August 7, 2025, for the supply of Dupixent 300 mg/2 mL pen injections. The contract represents a firm fixed-price delivery order with an ultimate completion date of August 8, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. This award was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWU47Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Dupixent 300 mg/2 ml syringes with a ceiling value of $3,418.92. This delivery order represents a firm fixed price contract with no set-aside designation, indicating it was competitively awarded through open procurement. The order is scheduled for ultimate completion by August 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. As a comprehensive global pharmaceutical support vehicle, this prime IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Dupixent, a specialty pharmaceutical product, aligns with the company's portfolio of brand-name medications supplied through the Defense Logistics Agency to support Defense Health Agency and military healthcare system requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 8/8/25 |